tiprankstipranks
Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP

Acurx Pharmaceuticals (ACXP) Financial Statements

114 Followers

Acurx Pharmaceuticals Financial Overview

Acurx Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.185; its P/E ratio is -2.05; Acurx Pharmaceuticals is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.38M$ -5.11M$ -3.11M$ -3.45M$ -2.90M
EBITDA$ -4.38M$ -5.11M$ -3.11M-$ -2.90M
Net Income Common Stockholders$ -4.38M$ -5.11M$ -3.12M$ -3.45M$ -2.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.90M$ 7.50M$ 7.10M$ 9.10M$ 7.20M
Total Assets$ 9.11M$ 7.71M$ 7.21M$ 9.19M$ 7.41M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -8.90M$ -7.50M$ -7.10M$ -9.10M$ -7.20M
Total Liabilities$ 3.11M$ 3.04M$ 3.22M$ 3.02M$ 2.07M
Stockholders Equity$ 6.00M$ 4.67M$ 3.93M$ 6.22M$ 5.31M
Cash Flow-
Free Cash Flow$ -3.06M$ -4.20M$ -2.09M-$ -1.93M
Operating Cash Flow$ -3.06M$ -4.20M$ -2.09M$ -1.58M$ -1.93M
Investing Cash Flow-----
Financing Cash Flow$ 4.51M$ 4.62M-$ 3.54M-
Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History

Acurx Pharmaceuticals Debt to Assets

Acurx Pharmaceuticals Cash Flow

Acurx Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis